Unthinkable? EU considers getting a vaccine boost from Russia's Sputnik

Publicly, the European Union has dismissed Russia's global coronavirus vaccine supply campaign as a propaganda stunt by an undesirable regime.

Gilead, Merck collaborate to develop long-acting HIV treatment

Gilead Sciences Inc has entered into an agreement with Merck & Co Inc to develop a long-acting HIV treatment, the drug makers said on Monday.

Exclusive: Regular booster vaccines are the future in battle with COVID-19 virus, expert says

Regular booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain's effort to sequence the virus's genomes told Reuters.

Indonesia holds off on AstraZeneca vaccine, awaits WHO review

Indonesia will delay the administering of AstraZeneca's COVID-19 vaccine due to reports of blood clots among some recipients in Europe and would await a review from the World Health Organization (WHO), its health minister said on Monday.

Thailand clears AstraZeneca use as potential side-effects divide Europe

Thailand announced plans on Monday to go ahead with AstraZeneca's COVID-19 vaccine and Germany said it would continue to administer the shot despite other countries suspending its use over safety fears.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

South Korean province orders COVID testing for foreigners, sparking complaints of xenophobia

South Korea's most populous province has ordered all of its foreign workers to be tested for COVID-19 by March 22, sparking complaints of long lines and logistical problems, as well as of implicit xenophobia in government messaging.

Factbox: Latest on the worldwide spread of the coronavirus

AstraZeneca said a review of safety data of people vaccinated with its COVID-19 shot has shown no evidence of an increased risk of blood clots, as Ireland and the Netherlands joined nations such as Denmark and Norway in temporarily halting use of the vaccine.

Focus: Money, talent flowing into mRNA sector after COVID-19 success

The success of COVID-19 vaccines based on messenger RNA (mRNA) is smoothing the way for using the novel technology not only in other vaccines, but possibly as treatments for cystic fibrosis, cancer and other hard-to-treat diseases.

Factbox: Companies developing mRNA treatments and vaccines

The United States has cleared the use of vaccines using messenger RNA (mRNA) to create an immune response from Moderna Inc and partners BioNTech SE and Pfizer Inc, boosting confidence in the novel technology.

Dane who died from blood clot after AstraZeneca shot had `unusual symptoms', agency says

A 60-year old Danish woman who died of a blood clot after receiving AstraZeneca's COVID-19 vaccine had "highly unusual" symptoms, according to the Danish Medicines Agency.

Related Videos

Americans say: No vaccine? No flight -poll

Pfizer to exceed vaccine production target by 20%